Twenty (24%) patients had HER2 positive tumours, and positive HER2 status was commoner in JC (14/32, 44% versus 2/18, 11% in OC and 4/35, 11% in GC; χ2 = 11.66, P = 0.003), Table 1. This evidence concerns the gene ERBB2 and gastric cancer.